TY - JOUR
T1 - Fasting criteria for screening: test properties and agreement with glucose tolerance
AU - Daniel, Mark
AU - Rowley, Kevin G.
AU - O'Dea, Kerin
PY - 2002/11
Y1 - 2002/11
N2 - The objective of this study was to characterise test properties and agreement for fasting glucose cut-offs used for screening diabetes in Indigenous Australian communities, across a range of diabetes prevalence. The oral glucose tolerance test (OGTT) was administered to adult volunteers (n=3249) for community-based diabetes screening in isolated settlements (n=25). Two-hour post-load glucose concentration was the 'gold standard' against which test properties were characterised for fasting plasma glucose cut-offs at concentrations of ≥7.0 mmol/l (ADA criterion) and ≥7.8 mmol/l (WHO criterion). Test sensitivity (95% CI) was greater for the ADA (72.5%, 67.4-77.1%) versus the WHO criterion (61.5%, 56.1-66.6%). Specificity was high (>98%) using either criterion. The post-test likelihood of diabetes, given a population prevalence of 14.8%, was 89.1% using the ADA criterion, and 94.9% using the WHO criterion. The ADA criterion gave better agreement than did the WHO criterion for diabetes prevalence ≥8.6%, and the probability of false results was lower using the ADA criterion, when diabetes prevalence was ≥12.8%. According to the ADA criterion most individuals ascribed false negative results were aged ≥35 years, overweight/obese, or had impaired fasting glucose. The fasting glucose criterion of 7.0 mmol/l was superior to 7.8 mmol/l in screening for diabetes.
AB - The objective of this study was to characterise test properties and agreement for fasting glucose cut-offs used for screening diabetes in Indigenous Australian communities, across a range of diabetes prevalence. The oral glucose tolerance test (OGTT) was administered to adult volunteers (n=3249) for community-based diabetes screening in isolated settlements (n=25). Two-hour post-load glucose concentration was the 'gold standard' against which test properties were characterised for fasting plasma glucose cut-offs at concentrations of ≥7.0 mmol/l (ADA criterion) and ≥7.8 mmol/l (WHO criterion). Test sensitivity (95% CI) was greater for the ADA (72.5%, 67.4-77.1%) versus the WHO criterion (61.5%, 56.1-66.6%). Specificity was high (>98%) using either criterion. The post-test likelihood of diabetes, given a population prevalence of 14.8%, was 89.1% using the ADA criterion, and 94.9% using the WHO criterion. The ADA criterion gave better agreement than did the WHO criterion for diabetes prevalence ≥8.6%, and the probability of false results was lower using the ADA criterion, when diabetes prevalence was ≥12.8%. According to the ADA criterion most individuals ascribed false negative results were aged ≥35 years, overweight/obese, or had impaired fasting glucose. The fasting glucose criterion of 7.0 mmol/l was superior to 7.8 mmol/l in screening for diabetes.
KW - American Diabetes Association (ADA)
KW - Australia
KW - Diabetes mellitus
KW - Diagnostic criteria
KW - Indigenous
KW - Screening
KW - Tests
KW - World Health Organisation (WHO)
UR - http://www.scopus.com/inward/record.url?scp=0036836783&partnerID=8YFLogxK
U2 - 10.1016/S0168-8227(02)00133-X
DO - 10.1016/S0168-8227(02)00133-X
M3 - Article
C2 - 12213356
AN - SCOPUS:0036836783
SN - 0168-8227
VL - 58
SP - 139
EP - 148
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
IS - 2
ER -